127 related articles for article (PubMed ID: 31520878)
1. Vanadium(V) tris-3,5-di-tert-butylcatecholato complex: Links between speciation and anti-proliferative activity in human pancreatic cancer cells.
Griffin E; Levina A; Lay PA
J Inorg Biochem; 2019 Dec; 201():110815. PubMed ID: 31520878
[TBL] [Abstract][Full Text] [Related]
2. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
3. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
[TBL] [Abstract][Full Text] [Related]
4. Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?
Levina A; Lay PA
Chem Asian J; 2017 Jul; 12(14):1692-1699. PubMed ID: 28401668
[TBL] [Abstract][Full Text] [Related]
5. Vanadium-based, extended catalytic lifetime catechol dioxygenases: evidence for a common catalyst.
Yin CX; Finke RG
J Am Chem Soc; 2005 Jun; 127(25):9003-13. PubMed ID: 15969577
[TBL] [Abstract][Full Text] [Related]
6. Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes.
Levina A; Uslan C; Murakami H; Crans DC; Lay PA
Inorg Chem; 2023 Oct; 62(43):17804-17817. PubMed ID: 37858311
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and mechanistic studies of vanadium-based, extended catalytic lifetime catechol dioxygenases.
Yin CX; Finke RG
J Am Chem Soc; 2005 Oct; 127(40):13988-96. PubMed ID: 16201821
[TBL] [Abstract][Full Text] [Related]
8. A Short-Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections.
Levina A; Pires Vieira A; Wijetunga A; Kaur R; Koehn JT; Crans DC; Lay PA
Angew Chem Int Ed Engl; 2020 Sep; 59(37):15834-15838. PubMed ID: 32598089
[TBL] [Abstract][Full Text] [Related]
9. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
[TBL] [Abstract][Full Text] [Related]
10. Vanadium(IV/V) complexes of Triapine and related thiosemicarbazones: Synthesis, solution equilibrium and bioactivity.
Kowol CR; Nagy NV; Jakusch T; Roller A; Heffeter P; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2015 Nov; 152():62-73. PubMed ID: 26349014
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
12. Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions.
Webb MI; Wu B; Jang T; Chard RA; Wong EW; Wong MQ; Yapp DT; Walsby CJ
Chemistry; 2013 Dec; 19(50):17031-42. PubMed ID: 24203647
[TBL] [Abstract][Full Text] [Related]
13. Autoxidation-product-initiated dioxygenases: vanadium-based, record catalytic lifetime catechol dioxygenase catalysis.
Yin CX; Sasaki Y; Finke RG
Inorg Chem; 2005 Nov; 44(23):8521-30. PubMed ID: 16270992
[TBL] [Abstract][Full Text] [Related]
14. Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin.
Zhang Y; Ho A; Yue J; Kong L; Zhou Z; Wu X; Yang F; Liang H
Eur J Med Chem; 2014 Oct; 86():449-55. PubMed ID: 25200980
[TBL] [Abstract][Full Text] [Related]
15. Vanadium(V) complexes of a tripodal ligand, their characterisation and biological implications.
Maurya MR; Uprety B; Avecilla F; Adão P; Costa Pessoa J
Dalton Trans; 2015 Oct; 44(40):17736-55. PubMed ID: 26399883
[TBL] [Abstract][Full Text] [Related]
16. The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities.
Du S; Feng J; Lu X; Wang G
Dalton Trans; 2013 Jul; 42(26):9699-705. PubMed ID: 23680987
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, immunomodulation and cytotoxic effects of vanadium (IV) complexes.
Ashiq U; Jamal RA; Mesaik MA; Mahroof-Tahir M; Shahid S; Khan KM
Med Chem; 2014 May; 10(3):287-99. PubMed ID: 23876231
[TBL] [Abstract][Full Text] [Related]
18. The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes.
Zhang Y; Yang XD; Wang K; Crans DC
J Inorg Biochem; 2006 Jan; 100(1):80-7. PubMed ID: 16321441
[TBL] [Abstract][Full Text] [Related]
19. Catechol oxidase activity of a series of new dinuclear copper(II) complexes with 3,5-DTBC and TCC as substrates: syntheses, X-ray crystal structures, spectroscopic characterization of the adducts and kinetic studies.
Banu KS; Chattopadhyay T; Banerjee A; Bhattacharya S; Suresh E; Nethaji M; Zangrando E; Das D
Inorg Chem; 2008 Aug; 47(16):7083-93. PubMed ID: 18624404
[TBL] [Abstract][Full Text] [Related]
20. In vitro apoptosis-induction, antiproliferative and BSA binding studies of a oxidovanadium(V) complex.
Kongot M; Dohare N; Reddy DS; Pereira N; Patel R; Subramanian M; Kumar A
J Trace Elem Med Biol; 2019 Jan; 51():176-190. PubMed ID: 30466929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
